Physician profile
Eric Klausner
NPI 1518982982
$1,171.85
in general payments reported to CMS, 2019-2025
19 companies · $280 in 2025
The $280 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $254 · 2020: $12.93 · 2021: $34.99 · 2022: $153 · 2023: $352 · 2024: $84.16 · 2025: $280.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $716.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $716.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organogenesis INC. | $195.31 | 2019-2025 | Puraply Wound Matrix |
| Lifenet Health | $148.04 | 2025 | Theragenesis Wound Matrix |
| Advanced Oxygen Therapy INC. | $123.42 | 2023-2025 | Topical Oxygen Chamber For Extremities, Topical Oxygen Chamber For Extremities |
| Abbvie INC. | $121.06 | 2022-2024 | |
| Smith+Nephew, INC. | $100.92 | 2021-2024 | Collagenase Santyl, Regranex |
| Medtronic Vascular, INC. | $95.42 | 2019 | |
| Baxter Healthcare | $68.35 | 2023 | Hillrom - Cardiac Ambulatory Monitor |
| Osiris Therapeutics INC. | $51.62 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $42.99 | 2023 | Jardiance |
| Hologic Sales and Service, LLC | $37.01 | 2023 | Aptima |
| Glaxosmithkline, LLC. | $29.77 | 2019 | |
| Misonix INC | $29.29 | 2019 | |
| Davol INC. | $23.02 | 2023 | Arista Ah Flexitip |
| Novo Nordisk INC | $22.24 | 2023 | Ozempic, Rybelsus |
| Bayer Healthcare Pharmaceuticals INC. | $20.40 | 2023 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tactile Systems Technology INC | $19.75 | 2021 | |
| Amgen INC. | $17.82 | 2024 | Otezla, Repatha |
| Abbott Laboratories | $13.20 | 2023 | Freestyle Libre 2 |
| Lilly USA, LLC | $12.22 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Klausner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.